BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16683225)

  • 1. Selecting patients for breast-conserving therapy: the importance of lobular histology.
    Morrow M; Keeney K; Scholtens D; Wei J; Steel J; Khan SA
    Cancer; 2006 Jun; 106(12):2563-8. PubMed ID: 16683225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
    Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
    Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy.
    Mullenix PS; Cuadrado DG; Steele SR; Martin MJ; See CS; Beitler AL; Carter PL
    Am J Surg; 2004 May; 187(5):643-6. PubMed ID: 15135683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.
    Warneke J; Berger R; Johnson C; Stea D; Villar H
    Am J Surg; 1996 Nov; 172(5):496-500. PubMed ID: 8942552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.
    Molland JG; Donnellan M; Janu NC; Carmalt HL; Kennedy CW; Gillett DJ
    Breast; 2004 Oct; 13(5):389-96. PubMed ID: 15454194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC; Horst K
    Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
    Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.
    O'Sullivan MJ; Li T; Freedman G; Morrow M
    Ann Surg Oncol; 2007 Nov; 14(11):3133-40. PubMed ID: 17653798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW; Bilous AM; Boyages J
    Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
    Huston TL; Pigalarga R; Osborne MP; Tousimis E
    Am J Surg; 2006 Oct; 192(4):509-12. PubMed ID: 16978962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
    Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.